In patients with STEMI and CTO, PCI for CTO is safe, feasible

19.11.20152256
In patients with STEMI treated with primary percutaneous coronary intervention, undergoing PCI for chronic total occlusion within a week of STEMI appears to be safe and feasible, according to results from the EXPLORE trial presented at the annual TCT Scientific Symposium.

Moderate Coffee Drinking May Prevent Early Death

18.11.20151730
Host of risks reduced in those drinking up to five cups per day.

Bivalirudin noninferior to heparin in patients undergoing TAVR

17.11.20151726
The use of bivalirudin as an anticoagulant in patients with severe, symptomatic aortic stenosis undergoing transcatheter aortic valve replacement was noninferior to heparin, according to study results from the BRAVO 3 study presented at the annual TCT Scientific Symposium.

PRADA: Candesartan prevents LVEF decline in women treated for breast cancer

16.11.20152518
In women treated for early breast cancer, the angiotensin receptor blocker candesartan protected against a decline in left ventricular ejection fraction, but the beta-blocker metoprolol did not, researchers reported here.

Conversion from AF to sinus rhythm shorter, more effective with vernakalant vs. ibutilide

13.11.20152106
Patients with atrial fibrillation who received the novel antiarrthyhmic drug vernakalant had faster conversion time to sinus rhythm and greater conversion success than patients assigned ibutilide.

Abstract submission to the EAS Congress 2016 is open!

12.11.20151750
Be part of EAS 2016 - an outstanding scientific programme covering recent developments in the field of atherosclerosis-related disease and clinical therapies.

Dyspnea, bleeding most common causes of ticagrelor discontinuation

12.11.20151917
The most frequent causes of ticagrelor discontinuation in the PEGASUS?TIMI 54 study were dyspnea and bleeding, and many of those events were minor, according to results of a substudy presented at the American Heart Association Scientific Sessions.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.